Growth Metrics

Eli Lilly (LLY) Property, Plant & Equipment (Net) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.56%
Dec 31, 2025 10.57%
Sep 30, 2025 8.70%
Jun 30, 2025 11.13%
Mar 31, 2025 8.02%
Dec 31, 2024 5.75%
Sep 30, 2024 9.05%
Jun 30, 2024 8.85%
Mar 31, 2024 5.50%
Dec 31, 2023 8.85%
Sep 30, 2023 5.19%
Jun 30, 2023 6.93%
Mar 31, 2023 3.96%
Dec 31, 2022 8.94%
Sep 30, 2022 2.01%
Jun 30, 2022 0.28%
Mar 31, 2022 1.31%
Dec 31, 2021 0.73%
Sep 30, 2021 0.73%
Jun 30, 2021 2.61%
Mar 31, 2021 -0.60%
Dec 31, 2020 4.84%
Sep 30, 2020 3.76%
Jun 30, 2020 1.05%
Mar 31, 2020 0.32%
Dec 31, 2019 0.92%
Sep 30, 2019 -0.59%
Jun 30, 2019 0.87%
Mar 31, 2019 -2.70%
Dec 31, 2018 -9.28%
Sep 30, 2018 0.49%
Jun 30, 2018 -2.09%
Mar 31, 2018 1.49%
Dec 31, 2017 2.65%
Sep 30, 2017 0.18%
Jun 30, 2017 1.87%
Mar 31, 2017 2.10%
Dec 31, 2016 0.01%
Sep 30, 2016 2.30%
Jun 30, 2016 0.41%
Mar 31, 2016 -0.25%
Dec 31, 2015 -0.27%
Sep 30, 2015 0.66%
Jun 30, 2015 0.90%
Mar 31, 2015 -0.17%
Dec 31, 2014 -0.99%
Sep 30, 2014 -0.71%
Jun 30, 2014 1.63%
Mar 31, 2014 -0.06%
Dec 31, 2013 2.68%
Sep 30, 2013 1.71%
Jun 30, 2013 0.17%
Mar 31, 2013 -1.76%
Dec 31, 2012 1.59%
Sep 30, 2012 0.25%
Jun 30, 2012 -1.74%
Mar 31, 2012 -0.07%
Dec 31, 2011 -0.66%
Sep 30, 2011 -1.78%
Jun 30, 2011 -0.18%
Mar 31, 2011 0.34%
Dec 31, 2010 -0.02%
Sep 30, 2010 2.02%
Jun 30, 2010 -2.54%
Mar 31, 2010 -2.57%